Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation

Respiration

Volumn 65, Issue 3, 1998, Pages 199-204

  Oddera, S ^a   Silvestri, M ^a   Testi, R ^b   Rossi, G A ^a  

^a G GASLINI INSTITUTE   (Italy)

^b GSK   (Italy)

Author keywords

2 adrenoreceptor agonists; Atopy; Cytokines; Dermatophagoides pteronyssinus; Glucocorticosteroids; Lymphocytes; Monocytes

Indexed keywords

ALLERGEN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SALMETEROL; THYMIDINE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGONIST; ARTICLE; BLOOD; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ALLERGENS; CELL DIVISION; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DRUG SYNERGISM; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 0031838170     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029260     Document Type: Article

References (37)

1. Global Initiative for Asthma. National Institutes of Health, National Heart, Lung and Blood Institutes, Publ No 95-3659, Jan 1995, pp 1-8.
2. Kay AB: Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-907.
3. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR: The specificity and regulation of T-cell responsiveness to allergen. Annu Rev Immunol 1991;9:67-95.
4. Walker V, Virchow J-C Jr, Bruijnzeel PLB, Basler K: T-cell subsets and their soluble products in allergic and nonallergic asthma. J Immunol 1991;146:1829-1835.
5. Parronchi P, Macchia D, Piccinni AP, et al: Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokines production. Proc Natl Acad Sci USA 1991;88:4538.
6. Robinson DS, Durham SR, Kay AB: Cytokines in asthma. Thorax 1993;48:845-853.
7. Barnes BJ: Beta adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:828-860.
8. Nelson HS: β-Adrenergic bronchodilators. N Engl J Med 1995;333:499-506.
9. Baker JA, Chediak AJ, Baier HJ, Wanner A: Tracheal mucosal blood flow responses to autonomic agonists. J Appl Physiol 1988;65:829-834.
10. Sanderson MJ, Dirksen ER: Mechanosensitive and beta-adrenergic control of ciliary beat frequency of mammalian respiratory tract cells in culture. Am Rev Respir Dis 1989;139:432-440.
11. Barnes PJ: Modulation of neurotransmission in airways. Physiol Rev 1992;72:699-729.
12. 2-adrenergic receptors in the trachea by autoradiography. Exp Lung Res 1983;5:183-192.
13. Bishopric NH, Cohen HJ, Lefkowitz RJ: Beta adrenergic receptors in lymphocyte subpopulations. J Allergy Clin Immunol 1980;65:29-33.
14. Butchers PR, Vardley CJ, Johnson M: Salmeterol: A potent and long-acting inhibitor of inflammatory release from human lung. Br J Pharmacol 1991;104:672-676.
15. Linden M: The effects of β-adrenoreceptor agonists and a corticoid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol 1992;107:156-160.
16. 2-Adrenergic receptor-mediated suppression of interleukin-2 receptors in human lymphocytes. J Immunol 1987;139:3355-3359.
17. Oddera S, Silvestri M, Scarso L et al: Salmeterol inhibits the allergen-induced mononuclear cell proliferation and downregulates GM-CSF release and HLA-DR expression by monocytes. Pulm Pharmacol 1997;10:43-49.
18. Robinson DS, Durham SR, Kay AB: Cytokines in asthma. Thorax 1993;48:845-853.
19. Andersson U, Andersson J, Lindfors A et al: Simultaneous production of interleukin-2, interleukin-4 and interferon-γ by activated human blood lymphocytes. Eur J Immunol 1990; 20:1591-1596.
20. 1 murine HTL clones. J Immunol 1988;140: 4245-4252.
21. Fernandez-Botran R, Sanders VM, Mosmann TR et al: Lymphokine-mediated regulation of the proliferative response of clones of TH1 and TH2 cells. J Exp Med 1988;168:543-558.
22. Knudsen PJ, Dinarello CA, Strom TB: Glucocorticoids inhibit transcriptional and posttranscriptional expression of interleukin-1 in U937 cells. J Immmunol 1987;139:4129-4134.
23. Reeds JC, Nowell PC, Hoover RG: Regulation of c-myc mRNA levels in normal human lynphocytes by modulators of cell proliferation. Proc Natl Acad Sci USA 1985;82:4221-4226.
24. Nouri G, Nouri ME: Comparison of the inhibition by glucocorticosteroids and cyclosporin A of mitogen-stimulated human lymphocyte proliferation. Clin Exp Immunol 1981;44:287-292.
25. Guyre PM, Girard MT, Morganelli PM, Manginiello PD: Glucocorticoid effects on the production and action of immune cytokines. J Steroid Biochem 1988;30:89-93.
26. Kern JA, Lab RJ, Reed JL, et al: Dexamethasone inhibition of interleukin-1-beta production by human monocytes. Post-transcriptional mechanisms. J Clin Invest 1988;81:237-244.
27. Shaw G, Kramer R: A conserved AU sequence from the 3′ untranslated region of GM-CSF on RNA mediates selective mRNA degradation. Cell 1986;46:659-667.
28. Mercier L, Thompson EB, Simons SS: Dissociation of steroid binding to receptors and steroid induction of biological activity in glucocorticoid-responsive cells. Endocrinology 1983;112:601-607.
29. Sekut L, Champion BR, Page K et al: Antiinflammatory activity of salmeterol: Down-regulation of cytokines production. Clin Exp Immunol 1995;99:461-466.
30. Lipworth B, Grove A: Evaluation of partial β-receptor agonist activity. Br J Clin Pharmacol 1997;43:9-14.
31. 2-agonists: Greater protection against adenosine monophosphate-than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1994;149:381-387.
32. 2-adrenergic receptor transcription in human lung. Am J Physiol 1995;12:L41-L46.
33. Pedersen B, Dahl R, Larsen BB, Venge P: The effects of salmeterol on the early-and late-phase reaction to bronchial allergen and post-challenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein and serum eosinophil protein X. Allergy 1993;48:377-382.
34. 4 excretion. J Allergy Clin Immunol 1992;89: 574-583.
35. 2-agonist and steroid dry powder inhaler in asthma. Am J Respir Crit Care Med 1995; 151:1053-1057.
36. Junniper EF, Johnston PR, Borkhoff CM et al: Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995;151:66-70.
37. Castle W, Fuller R, Hall J, Palmer J: Serevent Nationwide Surveillance Study: Comparison of salmeterol and salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1995;306:1034-1037.